EAU 2014 - Poster: An economic model to investigate differences in resource utilisation associated with the use of BOTOX® to manage urinary incontinence in patients with idiopathic overactive bladder in the United Kingdom

STOCKHOLM, SWEDEN (UroToday.com) - Presented by C. Loveman,¹ J. Millen,¹ R. Zeidman,² and L. Ruff¹ at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

¹Allergan Limited, Marlow, UK; ²Medaxial Group, London, UK